Flegnil (Carbocisteine) is a mucoregulator-mucolytic, for respiratory tract
disorders characterized by excessive viscous mucus, including E.N.T., disorders.

Flegnil (Carbocisteine) is indicated for chronic respiratory conditions like
bronchitis, bronchial obstruction as in asthma, bronchiectasis, upper respiratory
tract congestion, glue ear, otitis media, eustachian cattarrah, sinusitis,
rhinopharyngitis.

Dose
Adult    :    30 mg/kg daily in divided doses initially, then 20 mg/kg daily in
divided doses or 750 mg 3 times daily initially, then 1.5 g daily in
divided doses.
Child    :    Normal dose is 20 mg/kg daily in divided doses or 2-5 years 62.5 -125 mg
4 times daily, 6-12 years 250 mg 3 times daily.

There are no contraindications to the use of Carbocisteine.

Carbocisteine should not be taken by people with an active peptic ulcer.

There is no information on the use of Carbocisteine during lactation. While there
are no reports of teratogenic effects, the manufacturers do not recommend the
use of Carbocisteine in the first trimester.

Neither hazardous nor therapeutically useful interactions have been reported.

Adverse effects of Carbocisteine are occasional gastrointestinal irritations, rashes.

Flegnil? Suspension: Each 5 ml contains Carbocisteine BP 125 mg.
Flegnil-DS? Suspension: Each 5 ml contains Carbocisteine BP 250 mg.

Flegnil ? Suspension: Bottle containing 100 ml suspension.
Flegnil-DS? Suspension: Bottle containing 100 ml suspension.

Store in a cool and dry place protected from light.